Arachidonic acid supplementation for cognitive improvement in schizophrenia: a controlled study
This study is recruiting in China. It focuses on schizophrenia.
In China
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in China. It focuses on schizophrenia.
In ChinaThis study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ChinaThis study is recruiting in Canada. It focuses on Bipolarity.
In CanadaThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in Brazil.
In Belo HorizonteThis study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
In NiğdeThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
Multiple locations, including BethesdaThis study is recruiting in the United Kingdom. It focuses on Anxiety.
In United KingdomThis study is recruiting in Spain. It focuses on ADHD.
In SpainThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
Multiple locations, including HialeahHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.